FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2213332016> ?p ?o ?g. }

• W2213332016 endingPage "894" @default.
• W2213332016 startingPage "890" @default.
• W2213332016 abstract "Diastolic heart failure (DHF) is characterized by symptoms including reduced ventricular relaxation and compliance, resulting in congestion of pulmonary and systemic circulation. The curative effects of regular cardiac agents are ineffective. Thus, new agents are required to treat chronic cardiac failure. The aim of the present study was to examine the clinical effects of the combined treatment by optimal dose of furosemide (20 mg/day) and spironolactone (40 mg/day) on elderly patients with diastolic heart failure (DHF) [New York Heart Association (NYHA) 1‑2 grade]. A total of 93 patients diagnosed with DHF between February, 2013 and February, 2014 were enrolled in the present study. The patients were randomly divided into the furosemide group (20 mg/day, n=27), optimal dose group (20 mg/day furosemide+40 mg/day spirolactone, n=36), and large dose group (40 mg/day furosemide+100 mg/day spirolactone, n=30). Following treatment for one month, a comparison and analysis of the NYHA class, left ventricular ejection fraction (LVEF) and left ventricular end diastolic diameter (LVEDD), left ventricular wall segmental motion among the three groups were performed. The re‑hospitalization rate of heart failure and incidence of electrolyte disorder among the three groups was compared and their differences analysed. Compared with pretreatment, the NYHA classifications of the three groups after treatment were reduced and differences were statistically significant (P<0.05). By contrast, for the NYHA classification after treatment there was no statistical significance (P>0.05). Compared with pretreatment, LVEF of the optimal dose group increased, LVEDD decreased, and the average systolic myocardial peak velocity and early diastolic myocardial peak velocity of ventricular wall motion were reduced, with differences being statistically significant (P<0.05). By contrast, in the furosemide and large dose groups no statistical significance was identified before and after the treatment (P>0.05). Improvement of the optimal dose group following treatment was more significant than the remaining two groups, and differences were statistically significant (P<0.05). The re‑hospitalization rate of heart failure and incidence of electrolyte disorder in the optimal dose group following treatment were significantly less than the other two groups, and differences were statistically significant (P<0.05). In conclusion, the optimal dose (20 mg/day furosemide+40 mg/day spirolactone) significantly improved the clinical symptoms of elderly DHF patients (NYHA 1‑2 grade) and ameliorated their long‑term prognosis." @default.
• W2213332016 created "2016-06-24" @default.
• W2213332016 creator A5001450322 @default.
• W2213332016 creator A5002131421 @default.
• W2213332016 creator A5003796558 @default.
• W2213332016 creator A5016456840 @default.
• W2213332016 creator A5022217372 @default.
• W2213332016 creator A5034227028 @default.
• W2213332016 creator A5045525015 @default.
• W2213332016 creator A5049578678 @default.
• W2213332016 date "2015-12-31" @default.
• W2213332016 modified "2023-09-27" @default.
• W2213332016 title "Clinical effects of combined treatment by optimal dose of furosemide and spironolactone on diastolic heart failure in elderly patients" @default.
• W2213332016 cites W1965783061 @default.
• W2213332016 cites W1971090864 @default.
• W2213332016 cites W1987141738 @default.
• W2213332016 cites W2003877563 @default.
• W2213332016 cites W2054540751 @default.
• W2213332016 cites W2057636963 @default.
• W2213332016 cites W2101551652 @default.
• W2213332016 cites W2113711838 @default.
• W2213332016 cites W2150092242 @default.
• W2213332016 cites W2151618087 @default.
• W2213332016 cites W2152094259 @default.
• W2213332016 cites W2161289284 @default.
• W2213332016 cites W2164705414 @default.
• W2213332016 cites W2169118110 @default.
• W2213332016 cites W2187599141 @default.
• W2213332016 cites W2764148593 @default.
• W2213332016 doi "https://doi.org/10.3892/etm.2015.2967" @default.
• W2213332016 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4774326" @default.
• W2213332016 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/26998008" @default.
• W2213332016 hasPublicationYear "2015" @default.
• W2213332016 type Work @default.
• W2213332016 sameAs 2213332016 @default.
• W2213332016 citedByCount "7" @default.
• W2213332016 countsByYear W22133320162016 @default.
• W2213332016 countsByYear W22133320162019 @default.
• W2213332016 countsByYear W22133320162020 @default.
• W2213332016 countsByYear W22133320162022 @default.
• W2213332016 crossrefType "journal-article" @default.
• W2213332016 hasAuthorship W2213332016A5001450322 @default.
• W2213332016 hasAuthorship W2213332016A5002131421 @default.
• W2213332016 hasAuthorship W2213332016A5003796558 @default.
• W2213332016 hasAuthorship W2213332016A5016456840 @default.
• W2213332016 hasAuthorship W2213332016A5022217372 @default.
• W2213332016 hasAuthorship W2213332016A5034227028 @default.
• W2213332016 hasAuthorship W2213332016A5045525015 @default.
• W2213332016 hasAuthorship W2213332016A5049578678 @default.
• W2213332016 hasBestOaLocation W22133320161 @default.
• W2213332016 hasConcept C126322002 @default.
• W2213332016 hasConcept C164705383 @default.
• W2213332016 hasConcept C2776379505 @default.
• W2213332016 hasConcept C2777955127 @default.
• W2213332016 hasConcept C2778198053 @default.
• W2213332016 hasConcept C2779781611 @default.
• W2213332016 hasConcept C57900726 @default.
• W2213332016 hasConcept C71924100 @default.
• W2213332016 hasConcept C78085059 @default.
• W2213332016 hasConcept C84393581 @default.
• W2213332016 hasConceptScore W2213332016C126322002 @default.
• W2213332016 hasConceptScore W2213332016C164705383 @default.
• W2213332016 hasConceptScore W2213332016C2776379505 @default.
• W2213332016 hasConceptScore W2213332016C2777955127 @default.
• W2213332016 hasConceptScore W2213332016C2778198053 @default.
• W2213332016 hasConceptScore W2213332016C2779781611 @default.
• W2213332016 hasConceptScore W2213332016C57900726 @default.
• W2213332016 hasConceptScore W2213332016C71924100 @default.
• W2213332016 hasConceptScore W2213332016C78085059 @default.
• W2213332016 hasConceptScore W2213332016C84393581 @default.
• W2213332016 hasIssue "3" @default.
• W2213332016 hasLocation W22133320161 @default.
• W2213332016 hasLocation W22133320162 @default.
• W2213332016 hasLocation W22133320163 @default.
• W2213332016 hasLocation W22133320164 @default.
• W2213332016 hasOpenAccess W2213332016 @default.
• W2213332016 hasPrimaryLocation W22133320161 @default.
• W2213332016 hasRelatedWork W1949634191 @default.
• W2213332016 hasRelatedWork W1964205598 @default.
• W2213332016 hasRelatedWork W2028236103 @default.
• W2213332016 hasRelatedWork W2213332016 @default.
• W2213332016 hasRelatedWork W2352519969 @default.
• W2213332016 hasRelatedWork W2430265825 @default.
• W2213332016 hasRelatedWork W2475222081 @default.
• W2213332016 hasRelatedWork W2908418680 @default.
• W2213332016 hasRelatedWork W2965474825 @default.
• W2213332016 hasRelatedWork W4361243003 @default.
• W2213332016 hasVolume "11" @default.
• W2213332016 isParatext "false" @default.
• W2213332016 isRetracted "false" @default.
• W2213332016 magId "2213332016" @default.
• W2213332016 workType "article" @default.